News

New research has identified sections of DNA associated with altered regulation of gene expression underlying schizophrenia.

Richmond Pharmacology, one of the UK’s leading early-phase contract research organisations, have today opened their new research facility in London Bridge.

As a result of the collaboration, Metrion is now able to offer its clients access to High Throughput Screening (HTS) and Assay.Works assay validation technologies, including 384-well format screening and compound handling facilities.

A novel DNA cancer vaccine has shown promise by stimulating a therapeutic anti-tumor response against leukemia in mice.

Researchers have discovered that a key protein required for replicating DNA depends on electrons traveling through DNA.

MIT team automate their peptide synthesis platform.

Strategic technology deal strengthens IDBS’ single R&D data management platform.

Researchers have uncovered how two different conditions—a genetic immunodeficiency and delayed acquired immunity—can combine to produce a life-threatening infection.

Identification of a protein that appears to help tumour cells become more aggressive could help us to improve cancer therapies.

The way that EDH proteins assemble on the surface of a cell and reshape its membrane is being analysed using a multitude of techniques, including crystallography, microscopy and HPLC.